Centella asiatica — The Cognitive and Dermal Rejuvenator

Centella asiatica exerts its effects primarily through its pentacyclic triterpenoids, including asiaticoside and madecassoside. It activates the Nrf2/HO-1 antioxidant pathway, reducing oxidative stress and neuroinflammation. In the skin, it stimulates type I collagen synthesis via the SMAD signaling pathway and inhibits matrix metalloproteinases (MMPs), preventing collagen degradation. It also promotes mitochondrial biogenesis and function, contributing to its neuroprotective and anti-aging properties.

Human trials demonstrate modest benefits for cognitive function and skin health. A 2017 meta-analysis of 11 randomized controlled trials found improvements in mood and cognitive function, though results were mixed. Phase 1 trials (e.g., 2022) have confirmed the safety and bioavailability of standardized extracts in older adults. Topical applications have shown efficacy in improving skin elasticity and reducing signs of photoaging in clinical studies.

Typical human doses range from 500–1,000 mg/day of standard extract, or 60–120 mg/day of purified triterpenes (asiaticoside/madecassoside), usually divided into two doses. Topical formulations for skin aging and wound healing typically contain 0.1–5% standardized extract. Best taken with food to enhance absorption.

Generally well-tolerated in healthy adults. Mild adverse effects may include gastrointestinal upset, headache, or dizziness. Rare cases of hepatotoxicity have been reported with high doses or prolonged use, so liver function monitoring is advised for long-term supplementation. May interact with sedative medications and hepatotoxic drugs. Avoid during pregnancy and breastfeeding due to insufficient safety data.

Key Papers